|
Grigoryeva E.V., Voloshinova E.V., Balkisova D.M., Myasnikova А.S.
Difficulties in diagnosis and treatment of idiopathic cryoglobulinemic glomerulonephritis
|
№3 / 2024
|
|
Frolova N.F., Mutovina Z.Yu., Kobzar M.V., Arbolishvili G.N., Pavlov D.P., Shmeleva D.Yu., Manerov F.F., Lysenko M.A.
Clinical case of successful treatment of granulomatosis with polyangiitis
|
№3 / 2024
|
|
Yu.V. Korotchaeva, L.V. Kozlovskaya, N.B. Gordovskaya, A.I. Speranskii, S.Yu. Milovanova, S.V. Roschupkina
Serum and urinary interleukin-6 as a marker of activity of HCV-associated cryoglobulinemic nephritis: role in determination of efficacy of antiviral therapy in combination with rituximab
|
№6 / 2011
|
|
A.A. Pulin, E.Yu.Gornostaeva, S.V. Roschupkina, S.S. Gririna, L.V. Kozlovskaya
Succesful rituximab therapy of membranous nephropathy, resistant to standard immunosupressive treatment
|
№5 / 2011
|
|
N.A. Moukhin, L.V. Kozlovskaya, L.Yu. Milovanova, S.V. Tegai, N.B. Gordovskaya, T.M. Ignatova, I.S. Kudlinskii
HCV-associated cryoglobulinemic vasculitis with severe kidney involvement and B-cell lymphoma development. Monoclonal anti-CD-20 antibodies and antiviral therapy as options of prognosis improvement
|
№2 / 2011
|
|
N.A. Moukhin, E.N. Semenkova, O.G. Krivosheev , P.I. Novikov
Use of rituximab in severe ANCA-associated vasculitidis
|
№2 / 2010
|
Русский
